NEWS
The 2025 AD Scientific Index is here—explore updated university and researcher rankings!
New! Young University / Institution Rankings 2025
New! The 2025 Edition of the AD Scientific Index is now live!
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
"Exciting Update! The 2025 Edition of the AD Scientific Index is now live!
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
login
Login
person_add
Register
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
Compare & Choose
local_fire_department
Country Top Lists
Laurence Baker
University of Michigan - Ann Arbor / United States
Others
AD Scientific Index ID: 1289178
Edit Form
Registration, Add Profile,
Premium Membership
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Congresses (0)
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Laurence Baker's MOST POPULAR ARTICLES
1-)
Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT)SM Lippman, EA Klein, PJ Goodman, MS Lucia, IM Thompson, LG Ford, ...Jama 301 (1), 39-51, 200925562009
2-)
Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT)EA Klein, IM Thompson, CM Tangen, JJ Crowley, MS Lucia, PJ Goodman, ...Jama 306 (14), 1549-1556, 201119382011
3-)
Phase III randomized, intergroup trial assessing imatinib mesylate at two dose levels in patients with unresectable or metastatic gastrointestinal stromal tumors expressing the …CD Blanke, C Rankin, GD Demetri, CW Ryan, M Von Mehren, ...Journal of clinical oncology 26 (4), 626-632, 200812352008
4-)
Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trialHA Tawbi, M Burgess, V Bolejack, BA Van Tine, SM Schuetze, J Hu, ...The Lancet Oncology 18 (11), 1493-1501, 201711622017
5-)
Randomized phase II study of gemcitabine and docetaxel compared with gemcitabine alone in patients with metastatic soft tissue sarcomas: results of sarcoma alliance for …RG Maki, JK Wathen, SR Patel, DA Priebat, SH Okuno, B Samuels, ...Journal of Clinical Oncology 25 (19), 2755-2763, 20078532007
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept